148 related articles for article (PubMed ID: 11221853)
1. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
Cancer Res; 2001 Feb; 61(3):1214-9. PubMed ID: 11221853
[TBL] [Abstract][Full Text] [Related]
2. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
Tanner MM; Karhu RA; Nupponen NN; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola JJ
Am J Pathol; 1998 Jul; 153(1):191-9. PubMed ID: 9665480
[TBL] [Abstract][Full Text] [Related]
3. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
[TBL] [Abstract][Full Text] [Related]
4. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
6. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
7. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
[TBL] [Abstract][Full Text] [Related]
8. Aneuploidy in breast cancer: a fluorescence in situ hybridization study.
Shackney SE; Singh SG; Yakulis R; Smith CA; Pollice AA; Petruolo S; Waggoner A; Hartsock RJ
Cytometry; 1995 Dec; 22(4):282-91. PubMed ID: 8749778
[TBL] [Abstract][Full Text] [Related]
9. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
[TBL] [Abstract][Full Text] [Related]
10. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.
Unger K; Wienberg J; Riches A; Hieber L; Walch A; Brown A; O'Brien PC; Briscoe C; Gray L; Rodriguez E; Jackl G; Knijnenburg J; Tallini G; Ferguson-Smith M; Zitzelsberger H
Endocr Relat Cancer; 2010 Mar; 17(1):87-98. PubMed ID: 19858224
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas.
De Angelis PM; Stokke T; Beigi M; Flatberg G; Enger M; Haug K; Aass HC; Schjølberg A; Andresen PA; Ariansen S; Bø AS; Mjåland O; Clausen OP
Int J Cancer; 2007 Jun; 120(12):2734-8. PubMed ID: 17354231
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
[TBL] [Abstract][Full Text] [Related]
13. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
14. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between aneuploidy of chromosome 17 and amplification of HER-2/neu gene in the different histological type of breast cancer].
Kuroso K; Ueda Y; Mori Y
Rinsho Byori; 2004 Nov; 52(11):897-9. PubMed ID: 15658468
[TBL] [Abstract][Full Text] [Related]
16. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
17. High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors.
Hicks J; Muthuswamy L; Krasnitz A; Navin N; Riggs M; Grubor V; Esposito D; Alexander J; Troge J; Wigler M; Maner S; Lundin P; Zetterberg A
Cold Spring Harb Symp Quant Biol; 2005; 70():51-63. PubMed ID: 16869738
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
Xu J; Chambers AF; Tuck AB; Rodenhiser DI
Cancer Genet Cytogenet; 2008 Feb; 181(1):1-7. PubMed ID: 18262045
[TBL] [Abstract][Full Text] [Related]
19. Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
Merola R; Mottolese M; Orlandi G; Vico E; Cognetti F; Sperduti I; Fabi A; Vitelli G; Cianciulli AM
Eur J Cancer; 2006 Jul; 42(10):1501-6. PubMed ID: 16762541
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.
Corver WE; Middeldorp A; ter Haar NT; Jordanova ES; van Puijenbroek M; van Eijk R; Cornelisse CJ; Fleuren GJ; Morreau H; Oosting J; van Wezel T
Cancer Res; 2008 Dec; 68(24):10333-40. PubMed ID: 19074902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
